| FSMAX | OTCHX | FSMAX / OTCHX | |
| Total Expense Ratio | 0.04 | 1.03 | 3% |
| Annual Report Gross Expense Ratio | 0.04 | 1.04 | 3% |
| Fund Existence | 14 years | 21 years | - |
| Gain YTD | 13.303 | -9.554 | -139% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 41B | 14.4B | 285% |
| Annual Yield % from dividends | 0.43 | 0.00 | - |
| Returns for 1 year | 10.55 | -11.77 | -90% |
| Returns for 3 years | 67.63 | 16.93 | 400% |
| Returns for 5 years | 26.24 | -8.81 | -298% |
| Returns for 10 years | 118.30 | 81.15 | 146% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FMAG | 34.68 | 0.05 | +0.15% |
| Fidelity Magellan ETF | |||
| GSST | 50.65 | 0.01 | +0.02% |
| Goldman Sachs Ultra Short Bond ETF | |||
| LFAO | 168.64 | N/A | N/A |
| LifeX 2055 Longevity Income ETF | |||
| RDTE | 30.99 | -0.11 | -0.35% |
| Roundhill Russell 2000 0DTECovCllStgyETF | |||
| GNOM | 47.20 | -0.44 | -0.93% |
| Global X Genomics & Biotechnology ETF | |||